169 related articles for article (PubMed ID: 29576595)
1. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia - The SCELTA Trial.
Liotta F; Annunziato F; Castellani S; Boddi M; Alterini B; Castellini G; Mazzanti B; Cosmi L; Acquafresca M; Bartalesi F; Dilaghi B; Dorigo W; Graziani G; Bartolozzi B; Bellandi G; Carli G; Bartoloni A; Fargion A; Fassio F; Fontanari P; Landini G; Lucente EAM; Michelagnoli S; Orsi Battaglini C; Panigada G; Pigozzi C; Querci V; Santarlasci V; Parronchi P; Troisi N; Baggiore C; Romagnani P; Mannucci E; Saccardi R; Pratesi C; Gensini G; Romagnani S; Maggi E
Circ J; 2018 May; 82(6):1688-1698. PubMed ID: 29576595
[TBL] [Abstract][Full Text] [Related]
2. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
[TBL] [Abstract][Full Text] [Related]
4. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.
Smadja DM; Duong-van-Huyen JP; Dal Cortivo L; Blanchard A; Bruneval P; Emmerich J; Gaussem P
Cytotherapy; 2012 Feb; 14(2):232-9. PubMed ID: 22040109
[TBL] [Abstract][Full Text] [Related]
5. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma - Subanalysis of the Long-Term Clinical Outcomes Survey.
Shoji K; Yanishi K; Yoshimi R; Hamada N; Kondo K; Fujimoto K; Nakajima H; Kuwahara K; Higashi Y; Fukumoto Y; Murohara T; Matoba S;
Circ J; 2019 Feb; 83(3):662-671. PubMed ID: 30726805
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.
Kondo K; Yanishi K; Hayashida R; Shintani S; Shibata R; Murotani K; Ando M; Mizuno M; Fujiwara T; Murohara T; Matoba S;
Circ J; 2018 Mar; 82(4):1168-1178. PubMed ID: 29386474
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
[TBL] [Abstract][Full Text] [Related]
12. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
[TBL] [Abstract][Full Text] [Related]
13. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
[TBL] [Abstract][Full Text] [Related]
14. Autologous Bone Marrow Mononuclear Cell Implantation and Its Impact on the Outcome of Patients With Critical Limb Ischemia - Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
Pignon B; Sevestre MA; Kanagaratnam L; Pernod G; Stephan D; Emmerich J; Clement C; Sarlon G; Boulon C; Tournois C; Nguyen P
Circ J; 2017 Oct; 81(11):1713-1720. PubMed ID: 28603176
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
[TBL] [Abstract][Full Text] [Related]
16. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
Capiod JC; Tournois C; Vitry F; Sevestre MA; Daliphard S; Reix T; Nguyen P; Lefrère JJ; Pignon B
Vox Sang; 2009 Apr; 96(3):256-65. PubMed ID: 19207166
[TBL] [Abstract][Full Text] [Related]
17. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
[TBL] [Abstract][Full Text] [Related]
18. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
Higashi Y; Miyazaki M; Goto C; Sanada H; Sueda T; Chayama K
J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
[TBL] [Abstract][Full Text] [Related]
19. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia.
Madaric J; Valachovicova M; Paulis L; Pribojova J; Mateova R; Sebekova K; Postulkova L; Madaricova T; Bucova M; Mistrik M; Vulev I
Stem Cell Res Ther; 2017 Jul; 8(1):165. PubMed ID: 28697789
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
